Unit 4 · The interconnected muscle system
Treating one muscle always changes what its antagonist does
Every elevator has a depressor working against it, and relaxing one always shifts what the other does. This unit works through four clinical scenarios built around that single opposition — including one where the correct decision is not to treat the whole system.
Framing
Two forces in constant tension
The most clinically significant shift in aesthetic botulinum toxin type A (BTX-A) practice over the past decade has been moving away from treating isolated areas toward understanding the face as a dynamic system of opposing forces.
Elevators and depressors exist in a state of balance. Relaxing one without considering its antagonist creates predictable and avoidable complications — and every scenario in this unit is a variation on that single idea.
- Elevators ↑
- Frontalis (brow) · Levator labii superioris · Zygomaticus major and minor · Levator anguli oris · Risorius
- Depressors ↓
- Corrugator supercilii · Procerus · Depressor anguli oris (DAO) · Depressor labii inferioris · Mentalis · Platysma
Nothing on either list acts alone. Relax a depressor and its paired elevator is suddenly working against less resistance; relax an elevator and its depressor takes over unchallenged. The four scenarios below are the clinical consequences of forgetting that.
Learn · Scenario A — the medial–lateral brow trade
Why relaxing the depressors can lift a brow you never treated
Glabellar treatment relaxes the muscles pulling the medial brow down. On its own, that says nothing about what the muscle pulling the brow up is about to do.
You treat the corrugators and procerus for glabellar lines and leave the frontalis untouched. Predict what you are likely to see at review.
Hold your answer before you open this. The value is in having committed to a prediction first.
When the corrugators and procerus are relaxed, the medial brow loses its primary depressor influence. If the frontalis is not concurrently treated or assessed, a compensatory lateral brow elevation can result, as the mid-lateral frontalis fibres remain active while the medial fibres are no longer opposed.
The fix is not to avoid treating the glabellar complex — it is to assess the lateral frontalis fibres at the same visit and address them simultaneously with the glabellar complex where indicated.
This compensatory pattern is often described in clinic as a "Spock brow" or "Mephisto brow". The name is useful shorthand for discussing the finding with a patient or colleague — the mechanism, not the name, is what should guide the correction.
A patient presents with strong glabellar lines and receives bilateral corrugator and procerus treatment. At review, they report lateral brow elevation they find undesirable. This is most likely because:
Select an option to commit. The reasoning appears afterwards.
The corrugators and procerus are the medial brow's depressors. Once they are relaxed, the medial brow no longer has its usual downward pull — but the mid-lateral frontalis fibres were never treated, so they continue contracting exactly as before, now against less resistance. The visible result is a compensatory lateral brow elevation.
This is why glabellar treatment is planned alongside an assessment of the frontalis, not in isolation. Where lateral elevation is unwanted, addressing the lateral frontalis fibres at the same visit — rather than waiting for the patient to notice it at review — keeps the outcome consistent with what was actually intended.
Learn · Scenario B — the sole elevator
The frontalis is the only thing holding this brow up
Frontalis is the brow's only elevator. There is no second muscle to take over if it is switched off — which changes the risk calculus for every frontalis treatment decision.
A patient with Grade 4 horizontal forehead lines asks for standard-dose frontalis treatment. Before agreeing, predict what a proper assessment of brow position might change about that plan.
Hold your answer before you open this. The value is in having committed to a position first.
The frontalis is the sole brow elevator. In a patient with early brow ptosis who is using frontalis overactivity to compensate and maintain brow height, aggressive frontalis treatment will worsen the ptosis it has been masking.
Always assess brow resting position and compensatory activity before treating — regardless of how strong the frontalis activity looks on dynamic assessment.
A patient with Grade 4 frontalis but true brow ptosis may benefit more from minimal frontalis treatment plus brow repositioning adjuncts than from a standard-dose approach. The strength of the contraction is not, on its own, the basis for the dose.
A patient has Grade 4 horizontal forehead lines and requests standard-dose frontalis treatment. On dynamic assessment, their brow rests at the orbital rim, and frontalis activation appears to be compensating to maintain brow height. The most appropriate approach is:
Select an option to commit. The reasoning appears afterwards.
The frontalis is the sole elevator of the brow. Grade describes the strength of a contraction, not what that contraction is doing for the patient — here, it is compensating for early ptosis rather than producing an isolated dynamic line. Treating the muscle at a standard dose without assessing brow position removes the compensation along with the lines.
The appropriate approach is conservative frontalis treatment with reassessment, informed by brow resting position and compensatory activity assessed before the first unit is administered — with brow repositioning adjuncts considered where the ptosis is significant.
Learn · Scenario C — an antagonist that has to hold its own weight
One antagonist, two possible outcomes
The depressor anguli oris (DAO) pulls the corner of the mouth down. Relaxing it only produces a lift if the muscle doing the opposite job is strong enough to do that job.
You relax the DAO to correct downturned oral commissures. Predict what determines whether the patient sees a full lift at the corner of the mouth or only a partial one.
Hold your answer before you open this. The value is in having committed to a position first.
The DAO's antagonist is the levator anguli oris (LAO), which elevates the corner. Relaxing the DAO in isolation is effective when the LAO is of adequate strength — but if the LAO is also weak or hypotonic, treating the DAO produces only partial improvement.
Treating the lower face as a balanced system, rather than the DAO alone, produces more consistently satisfying outcomes.
A more comprehensive lower face approach may involve also assessing the mentalis, depressor labii inferioris, and orbicularis oris — not because every patient needs all three treated, but because the DAO does not act in isolation from any of them.
The depressor anguli oris (DAO) pulls the oral commissure inferiorly. Its direct anatomical antagonist — whose strength determines how complete the improvement will be when the DAO is treated alone — is:
Select an option to commit. The reasoning appears afterwards.
The DAO's direct antagonist is the levator anguli oris. Relaxing the DAO removes the downward pull at the commissure, but the visible lift still depends on the LAO having enough strength to do the elevating — the DAO's relaxation does not manufacture elevation on its own.
Where the LAO is weak or hypotonic, treating the DAO in isolation produces a partial result the patient may read as a treatment that "didn't work", when the actual issue is an antagonist that was never assessed. Checking LAO strength before treating DAO alone is what makes the outcome predictable.
Learn · Scenario D — when not to treat the system
When the correct decision is not to treat the whole system
Everything so far argues for assessing the antagonist before you treat. That is not the same as arguing you should always treat it.
A patient asks specifically for softening of dynamic forehead lines and is clear that she does not want to lose the ability to raise her brows in conversation. Predict whether the antagonist-aware approach in this unit calls for treating the full elevator/depressor complex here, or something narrower.
Hold your answer before you open this. The value is in having committed to a position first.
Sometimes the correct clinical decision is not to treat all interconnected muscles. A patient seeking softening of dynamic forehead lines without loss of expressivity may request — and receive — conservative frontalis treatment only.
Clinical nuance requires being able to assess when a targeted, concern-specific treatment is more appropriate than a holistic one. Assessing the whole system does not mean treating the whole system by default.
A patient with a specific functional concern — brow asymmetry driven by unilateral corrugator dominance, for example — may benefit from targeted unilateral treatment rather than a whole-face approach. The system-wide assessment still happens; the treatment plan that follows it does not have to be system-wide.
Never treat a muscle in isolation without actively considering the effect on its anatomical antagonist and neighbouring muscles. Document your assessment of the full muscle system, not just the muscle you are treating — the assessment is what makes a targeted decision defensible, and it is what makes a holistic one correct when that is the better call.
Unit 4 summary
Clinical takeaways
- Every muscle you treat has an antagonist that is now working against less resistance. Relaxing a depressor changes what its paired elevator does, and relaxing an elevator changes what its paired depressor does — the effect is never confined to the muscle you injected.
- The frontalis has no backup. As the brow's sole elevator, aggressive frontalis treatment in a patient using it to compensate for ptosis will worsen the ptosis it was masking — assess brow position before dosing by grade alone.
- An antagonist's strength sets the ceiling on your result. Relaxing the DAO only lifts the oral commissure as far as the levator anguli oris is strong enough to lift it — a weak LAO caps the outcome regardless of DAO technique.
- Treating the whole system is not always the correct call. A concern-specific, targeted treatment can be the better clinical decision — the antagonist still has to be assessed, but assessment and treatment are not the same decision.